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Abstract
Background: Basophils are circulating cells involved in hypersensitivity reactions and allergy but
many aspects of their activation, including the sensitivity to external triggering factors and the
molecular aspects of cell responses, are still to be focused. In this context, polychromatic flow
cytometry (PFC) is a proper tool to investigate basophil function, as it allows to distinguish the
expression of several membrane markers upon activation in multiple experimental conditions. 
Methods: Cell suspensions were prepared from leukocyte buffy coat of K2-EDTA anticoagulated
blood specimens; about 1500-2500 cellular events for each tested sample, gated in the lymphocyte
CD45dim area and then electronically purified as HLADRnon expressing/CD123bright, were
identified as basophilic cells. Basophil activation with fMLP, anti-IgE and calcium ionophore A23187
was evaluated by studying up-regulation of the indicated membrane markers with a two-laser six-
color PFC protocol.
Results: Following stimulation, CD63, CD13, CD45 and the ectoenzyme CD203c up-regulated
their membrane expression, while CD69 did not; CD63 expression occurred immediately (within
60 sec) but only in a minority of basophils, even at optimal agonist doses (in 33% and 14% of
basophils, following fMLP and anti-IgE stimulation respectively). CD203c up-regulation occurred in
the whole basophil population, even in CD63non expressing cells. Dose-dependence curves
revealed CD203c as a more sensitive marker than CD63, in response to fMLP but not in response
to anti-IgE and to calcium ionophore.
Conclusion:  Use of polychromatic flow cytometry allowed efficient basophil electronic
purification and identification of different behaviors of the major activation markers. The
simultaneous use of two markers of activation and careful choice of activator are essential steps
for reliable assessment of human basophil functions.
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Background
Human basophils, as other leukocytes, express several cell
membrane antigens which can be related to their immu-
nological responsiveness. Challenging basophils with
allergens or agonists may result in a modified expression
of these molecules on cell membrane, a mechanism that
can be evaluated by flow cytometry [1-5]. Furthermore,
the expression of membrane molecules could change also
while cells are responding to a pathology state [6-9] and/
or following a therapeutical treatment [10].
While most authors recognize the flow cytometric
approach as a proper tool to investigate basophil func-
tion, several problems and methodological issues are still
to be clarified, namely subject responsiveness (a broad
variability in basophil activity is evidenced between differ-
ent donors and different markers within the same donor),
sample treatment (which may affect cell activation state
and response pattern), gating procedure (which is a key
factor to separate selectively a small population like
basophils) and the selection of the best suitable activation
markers [11-13]. The discovery of new monoclonal anti-
bodies about membrane antigens has improved strategies
to analyze the basophil function [2,14-17]. However, to
the best of our knowledge, cytometry applied to basophil
activation study is currently restricted to a two-three color
measurement and to two light-scattered parameters
[13,18-20].
It is conceivable that the use, in the same analytical set-
ting, of more than two or three flow cytometry markers to
evaluate the behavior of several activation molecules may
render more informative the whole assay system [21].
Critical points, however, have raised a debate about the
actual cost-effectiveness of an analytical strategy using
more than three colors [5,21,22]. In this study we focused
on the kinetics of activation markers under different cell
conditions; to this purpose we needed a clear-cut distinc-
tion between phenotype and activation markers. Our pro-
tocol involved two steps. First, an electronic capture of
basophil leukocytes as low side-scattered cells in the
CD45expressing lymphocyte area: the use of CD45 contrib-
utes to discriminate basophil area from other leukocytes
excluding cellular debris [23]. Second, inside this area the
electronic capture of HLA-DRnon expressing/CD123bright cells
allows to identify pure basophils [24]. Although CD203c
is considered a selective marker for basophils [25] this
molecule is expressed at a low level in non-activated cells:
the use of such a weak marker as a phenotype tracer might
result into the exclusion of resting cells having a very low
CD203c expression from gating capture. An essential step
of this strategy is a clear-cut and quantitative evaluation of
the membrane molecule changes associated with cell acti-
vation. In particular we stressed on the differential behav-
ior of the main activation markers CD63 and CD203c in
the same experimental sample. Cellular responses to dif-
ferent agonists were followed by evaluating the behavior
of the activation markers CD63, CD203c, CD69 or CD13
compared to a resting state.
As working cell preparation, in this protocol, we used
basophil-enriched buffy coats, pooled from healthy blood
donors, in order to reduce possible effect of individual
sensitivity, to wash out plasma which could interfere with
anti-IgE activation, and to eliminate platelets which share
some activation markers with basophil (CD63) [5]. We
neither use Ficoll nor Percoll gradients in order to prevent
spontaneous activation of these cells and to keep as close
as possible a standard blood environment condition.
Moreover, we did not use IgE-labeling, since anti-IgE was
used as stimulatory agent, other leukocytes can be tar-
geted by anti-IgE and because FcåRI expression varies con-
siderably from one subject to another [4,11,26].
The choice of a multi-parametric approach allows to focus
onto the differential responsiveness of several markers
simultaneously and in the same sample even by the appli-
cation of correlated logical gates. This approach should
give more insight about the functional relationship
between activation molecules, about the optimal and
threshold doses for detecting cell activation, and could
facilitate subsequent studies about the role of these differ-
ent antigens as predictive diagnostic markers [17,27].
Materials and methods
Reagents and disposable ware
All reagents were prepared by using pure compounds in a
laminar flow hood and with disposable plastic ware.
HEPES ([4-(2-hydroxyethylpiperazine-1-ethanesulonic
acid], sodium-heparine 170 U/mg and salts were pur-
chased from Sigma-Aldrich, GmbH, Germany. Goat anti-
human monoclonal IgE was from Caltag, USA; N-formyl-
L-methionyl-L-leucyl-L-phenylalanine (fMLP), mouse
monoclonal anti-human-IgE (clone GE), 4-brome-cal-
cium ionophore A23187 and dimethylsulfoxide (DMSO)
were purchased from Sigma-Aldrich GmbH, Germany.
Anti-CD203c-PE (isotype IgG1, clone 97A6) was pur-
chased from Beckman Coulter Immunotech, USA, anti-
CD69-APC (isotype IgG1, clone FN50), anti-CD123-
PECy5 (isotype IgG1, clone 9F5), anti-CD13-APC (isotype
IgG1, clone WM15), anti-HLA-DR-PECy7 (isotype IgG2a,
clone L243), anti-CD45-APCCy7 (isotype IgG1, clone
2D1) and anti-CD63-FITC (isotype IgG1, clone H5C6)
were purchased from Becton Dickinson Pharmingen USA.
Vials and test tubes were purchased from (BD Falcon, NJ,
USA).
Basophil preparation
Basophils were collected by pooling the leukocyte buffy
coats drawn from venous K2-ethylen-diamino-tetra-aceticClinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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acid (EDTA) anticoagulated peripheral blood of at least
four healthy, non allergic, screened subjects (blood
donors) for each experiment [20]. Blood samples were
worked out within 2–3 hours from venous withdrawal
using a differential centrifugation step procedure. Blood
specimens were diluted 1:4 into an ice-kept or refrigerated
(+2°C/+8°C) HEPES modified buffer ([4-(2-hydrox-
yethylpiperazine-1-ethanesulonic acid] 20 mmol/L; NaCl
127 mmol/L; KCl 5 mmol/L; sodium-heparin 5 UI/ml,
pH 7.4) using sterile 14-ml polypropylene cap-equipped
round bottom tubes and centrifuged at 700 g for 15 min-
utes at +4°C. Leukocyte buffy-coat layers, contaminated
by erythrocytes, were individually collected, suspended in
the HEPES-heparin (HBE) buffered solution and centri-
fuged at 400 g for 10 minutes at +4°C. Pelletted buffy-
coats were washed out from surnatants, collected in a sin-
gle polypropylene tube, suspended in the ice-cold HBE
medium and centrifuged at 400 g for further 10 minutes.
Finally pooled leukocyte buffy-coats were suspended to
1:4 v/v compared to whole blood starting volume with the
refrigerated HBE buffer. In order to maintain basophils in
a resting state during the whole preparation procedure,
cells were treated with apyrogenic solutions and sterile
disposable plastic ware and kept into ice until use in order
to prevent any spontaneous activation [17]. An aliquot of
about 1 ml of the above HBE-suspended cell culture was
transferred to a Bayer ADVIA 2120 automated hematocy-
tometer for basophil counting and yield [28].
Cell treatment
fMLP was dissolved in dimethylsulfoxide (DMSO) as a 2
× 10-2 M stock solution, stored at -20°C and thawed
before use. Each solution was freshly prepared by diluting
fMLP in HBE supplemented with 5 mM CaCl2 and with 2
mM MgCl2 (HBC buffer) to 2× the final concentration, in
order to make the indicated working solutions. Anti-
human monoclonal IgE, purchased as mouse ascitic fluid
with a concentration of 7.3 mg/ml (4.87 × 10-5 moles/L),
or as purified goat-anti human (0.5 mg/ml) in buffered
saline with NaN3, was diluted in HBC buffer two times the
final molarity, in order to make the indicated working
concentrations. Calcium ionophore A23187 was dis-
solved in DMSO at the stock concentration of 10-3 mol/L
and then dissolved in HBC buffer to 2× the final concen-
tration, in order to make the indicated working solutions.
Ten minutes before incubation, the cell suspension was
diluted 1:1 v/v with HBE and brought at 37°C; dilution
was carried out to reduce homotypic aggregation follow-
ing cell activation [29]. Stimulation with agonists was per-
formed at 37°C for the indicated time inside round
bottom, cap-equipped polystyrene 5-ml (12 × 75 mm)
plastic test tubes. 50 μl of agonist or of control HBC for
resting samples were distributed in the test tubes and
brought to 37°C. Then 50 μl of the cellular buffered sus-
pension were added and incubation carried on for the
indicated time. Cell culture homogeneity was maintained
by gentle mixing test tubes every ten minutes. The incuba-
tion was then stopped by adding 100 μl of ice-cold HBE
buffer supplemented with 2.8 mmol/L Na3-EDTA and
samples were put on ice until staining with monoclonal
antibodies.
Staining with monoclonal antibodies
In order to choose the most suitable fluorochromes for
antibodies, we followed previously reported settings [30].
The protocol included tandem-dyes for cell phenotyping
and small organic molecules or proteins (FITC, PE and
APC) for the activation markers and used a 488 nm-633
nm two lasers equipped air flow cytometer (Becton Dick-
inson FACScanto). For tandem-dyes stability we followed
manufacturer's instructions. Staining protocols were per-
formed at 4°C for 20 minutes following manufacturer's
instructions and according to this pattern: 10 μl/200 μl
cell suspension for all the antibodies except for the follow-
ing markers CD45-APCCy7 and HLA-DR-PECy7 (5 μl/
200 μl cell suspension).
Preparation of flow cytometry samples
Soon after staining, samples underwent erythrocyte lysis
according Tsang's protocol [31]: lysis was performed with
3 ml of a +4°C refrigerated ammonium-chloride solution
(NH4Cl 155 mmol/L; Na2HCO3 10 mmol/L, Na3EDTA
0,10 mmol/L, pH = 7,2) for 2 minutes on ice, then cells
were pelleted at 500 g for 5 minutes in a refrigerated cen-
trifuge. Surnatants were removed and pellets gently resus-
pended in 0.5 ml of a BD-Isoflow phoshpate saline (PBS)
balanced buffer, just ready for flow cytometry assay.
Gating procedure
Basophils were gated as low side-scattered cells (SSC) in
the CD45dim lymphocyte area: the use of CD45 contrib-
uted to discriminate basophil area from other leukocytes
better than FSC/SSC light-scattering, excluding cellular
debris and to account for a further selective marker to phe-
notype basophilic cells [23]. This region was investigated
for HLADR and CD123 expression. Cellular events with a
HLADRnon expressing/CD123bright phenotype were then iden-
tified as basophils [24,32]. For each sample about 50,000
events were acquired in which, by applying this gating
protocol, approximately 1500–2500 basophils in the gate
were counted.
CD63 intracellular evaluation
To evaluate intracellular CD63, basophils were stained as
the above described methods excluding CD63-FITC. Then
the cells underwent a lytic treatment, were fixed with 4%
paraformaldehyde and permeabilized with 0.1% saponin
and 0.09% sodium azide phosphate balanced modified
buffer (BD CelLyse buffer) and finally stained with CD63-Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
Page 4 of 14
(page number not for citation purposes)
FITC as above. Samples were reconstituted in BD-Isoflow
PBS balanced buffer and read.
Cytometer and fluorochrome setting
Flow analysis was performed using a two laser BD FACS-
canto flow cytometer: this instrument has a 10.000
events/sec capability, six-color detection and 0,1% of
sample carryover. Analyses were performed with a mean
flow rate of 300–500 events/sec, setting an excess limit of
50,000 events to record in the basophil gate in order to
evaluate the whole buffered suspension volume and hav-
ing a proper estimation of cell recovery and reproducibil-
ity. Compensation followed cytometer manufacturer's
instruction according an off-line procedure by applying
automated electronics algorithms and preset templates,
by using bi-parametric logarithmic dot plots, gate-specific
tubes and single-tube data analysis, and optimizing FSC
threshold and fluorochrome voltage as set up parameters.
To evaluate fluorochrome unspecific staining, isotype
controls for anti-IgG1 and anti-IgG2α were introduced in
the preliminary procedure to set up photomultiplier and
instrument technical parameters; this control used a stain-
ing procedure carried out without introducing in the assay
system the fluorochrome of interest was also performed.
Sample analysis and data collection
Mean of fluorescence intensity (MFI) for each fluoro-
chrome-labeled monoclonal antibody was calculated
automatically with the cytometer software by averaging
the total fluorescence of the marker in the basophil gate.
As well percentage of activated cells was calculated by the
software considering the CD63-FITC bright cells counted
to the right of a threshold that was established including
the main peak of fluorescence of a sample of resting cells.
In order to reduce standard deviation due to brightly flu-
orescent cells respect to dimly ones, a logarithmic scale
and the coefficient of variation to measure variability dis-
persion were used. When necessary, Bigos' formula to nor-
malize brightness over background was applied [22].
Results
Basophils yield and electronic sorting
The samples from a total of 82 healthy subjects (38 males,
44 females, mean age 46.34 yrs ± 5.67 SD, range 26 to 65
yrs) were used, in a total of 21 experiments. Starting from
K2-EDTA anticoagulated peripheral blood with a WBC
×103/μl mean count of 6.41 ± 0.90 SD, corresponding to
a basophil concentration mean of 37.87 ± 10.70 SD cells/
μl, pooled buffy coats, having a mean count of 8.47 ± 2.09
SD WBCx103/μl and an estimated basophil concentration
of 92.25 ± 18.43 SD cells/μl, were obtained. This yield cor-
responds to an enrichment that is approximately 2.4
times in respect to starting whole blood.
Figure 1 shows a typical dot plot of basophil immuno-
logic phenotyping and electronic capture. HLADR-PECy7/
CD123-PECy5 plot, built using the CD45-dim cells in the
lymphocyte area (see methods), allowed the definition of
a well-isolated area of CD123bright cells, not expressing
HLA-DR (basophils) (Figure 1A) [32]. This electronic
cloud did not change its position upon activation with
any agonist (here the result with anti-IgE is shown, Figure
1B, see also Table 1 [see Additional file 1]). This last point
is particularly important in studies designed to investigate
the dynamics of activation markers compared to a basal,
resting state.
Mean fluorescence markers in the population
Table 1 [see Additional file 1] summarizes MFI results
concerning a series of experiments performed in our labo-
ratory. The data show the changes induced by the two ago-
nists employed on the different markers. Gating markers
(CD123 and HLADR) did not significantly change their
membrane expression under activation, while CD45 was
up-regulated by 2–3 times. Such an MFI increment extent
was also observed with CD203c triggered by fMLP or by
anti-IgE and with CD13 triggered with fMLP. CD63-FITC
MFI, very low in resting cells (mean 619.76), increased by
24 times following fMLP and by 4.8 times following anti-
human IgE stimulation. The mean percentage of CD63-
FITCbright cells increased from 3.12% to 33.44% following
fMLP activation and from 3.12% to about 13.67% follow-
ing anti-IgE stimulation. The N-aminopeptidase CD13
and the c-type lectin CD69 did not show, however, a
reproducible activation pattern in our assay condition,
which led us to focus on CD63 (lysosome-associated mem-
brane protein-3 or LAMP-3) and CD203c (ecto-nucleotide-
pyrophoshatase phosphodiesterase-3 or ENPP-3) markers
hereafter.
Basophil activation markers: CD63 and CD203c
Basophil response towards the different agonists was
examined following changes in the mean fluorescence
intensity (MFI) associated to specific membrane marker
fluorochrome and by evaluating dot plots of the acquired
events.
Figures 2 and 3 show a typical experiment of cell activa-
tion. Non activated basal (resting) basophils behaved as
typical non expressing cells for CD63 but expressing
CD203c, although at a low level (~3000 fluorescence
units) (Figure 2A and 2B): fluorescence histograms (Fig-
ure 2E and 2G) exhibited a normally distributed popula-
tion of both markers. Following 30 minutes of incubation
with 100 nM fMLP, a significant fraction of cells (41.4%)
showed a CD63 bright phenotype (Figure 2C and 2F),
while almost all basophils up-regulated CD203c mem-
brane expression (Figure 2D and 2H). The difference
between CD63 and CD203c expression following cellClinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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activation was even more striking using anti-human IgE as
stimulatory agent in a simultaneous assay of the same cell
preparation (Figure 3). Basal (resting) level of CD63 (Fig-
ure 3A) and of CD203c (Figure 3B) and their respective
fluorescence distribution (Figure 3E and 3G) were compa-
rable to those of the resting cells previously described. Fol-
lowing incubation with 10 μg/ml anti-IgE, CD63
membrane expression occurred with a lesser extent than
with fMLP triggering and at only 22.4% of the cells (Figure
3C and 3F), while the CD203c expression increased in all
basophils and at the same extent as with fMLP triggering
(Figure 3D and 3H).
These two major markers were examined in the same
biparametric dot plot (Figure 4). Resting (CD63 negative)
basophils showed a significant CD203c-fluorescence on
their membrane (Figure 4A), as expected. Following fMLP
(Figure 4B) and anti-human IgE (Figure 4C) stimulation,
basophils evidenced complex activation patterns, in
which a population of basophils expressing a CD63dim/
CD203cbright phenotype is clearly evident. This might indi-
cate: a) the presence of a CD203cbright basophil sub-popu-
lation lacking CD63 tetraspanin or b) that the CD63
dimly cells have this intracellular-associated protein 3 but
are unable to up-regulate it on the membrane. To examine
these issues, we investigated intracellular storage of CD63.
Figure 5 shows that all basophilic cells, having a CD63non
expressing phenotype on their membrane (Figure 5A and
5B), have a CD63expressing phenotype with intracellular
staining (Figure 5C and 5D). This suggests that CD63 is
present in all the cells but is upregulated (expressed on the
cell membrane) only in a few of them.
Dose response and time course
To evaluate the responsiveness of basophilic cells in order
to assess their normal function in our testing condition,
dose response and time course were performed. In fMLP
dose-response curves, CD203c appears the earlier marker
to be activated by formylated peptides: at a dose of 3 × 10-
9 M, CD203c MFI increased from 873 to 2765 (growing up
to three times) while CD63 reached the maximum of acti-
vation at 3 × 10-8 M (changing MFI from 179 to 4020).
Moreover, while CD63 up-regulation seems to go forward
up to 10-6 M fMLP, CD203c reached a maximum plateau
at the dose in which CD63 began to increase (Figure 6A).
On the other hand, with the agonist anti-IgE the two
Human basophils gating with the BD-FACScanto flow cytometer Figure 1
Human basophils gating with the BD-FACScanto flow cytometer. Leukocytes are immunologically gated in the 
CD45dim-lymphocyte area and electronically captured as cellular events in HLADRnon expressing/CD123bright biparametric logarith-
mic plot to distinguish them from other events and identified as basophils from monocytes (Q1), plasmacytoid dendritic cells 
(Q2) and lymphocytes (Q3). (A) Resting cells, (B) activation with 1 μg/ml goat anti-human IgE.Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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curves were parallel and there was no dissociation
between the two markers (Figure 6B).
Time-related response patterns were investigated using an
optimal stimulatory dose of formylated peptides (Figure
7). CD63 up-regulation occurred within the first minute
of activation while CD203c membrane reached the pla-
teau after about three minutes: the expression of both
markers was slightly down-regulated after 60 minutes fol-
lowing agonist treatment. A 15 to 30 minutes time
appears as optimal for the full expression of cell activation
using those markers.
In order to better describe the dissociation of two markers
observed with fMLP as agonist, the response of CD203c in
CD63non expressing basophils was evaluated (Figure 8).
CD203c dose response in the basophilic cell population
which did not express CD63 basophils was comparable to
that evaluated by taking into account all the basophils
(see also Figure 6A), indicating that sensitivity to fMLP did
not depend on the differential CD63 expressing subpopu-
lation.
To investigate a possible dissociation of two activation
markers at the level of the intracellular signaling, we
examined CD63 and CD203c dose response to the cal-
cium ionophore A23187. CD203c response to A23187
was similar to the response exhibited by CD63, both
markers reaching a peak close to 3 × 10-6 M A23187 (Fig-
ure 9).
Discussion
In this work human basophil activation was investigated
in vitro by using a two laser multiparameter flow cytome-
try, a technique that is becoming prevalent in immu-
nophenotyping. The latter was applied to leukocyte
preparations from buffy-coats of human blood samples,
yielding basophil enriched populations, with cell num-
bers sufficient to perform several activation studies under
different experimental conditions. As starting material,
Dot plots and histograms of CD63 and CD203c expression in response to fMLP Figure 2
Dot plots and histograms of CD63 and CD203c expression in response to fMLP. Basophils were incubated in the 
absence (A,B,E,G) and in the presence (C,D,F,H) of 10-7 M fMLP at 37°C for 30 minutes and gated basophils were plotted both 
as dot plots (A,B,C,D) and as histograms (E,F,G,H).Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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small (3 ml) samples of K2-EDTA-anticoagulated blood
were employed and allowed the preparation of cells that
proved to be in a basal, resting state and to be highly
responsive to in vitro stimulation. Besides providing
enriched and functional leukocyte samples, the overall
procedure of basophil isolation and pooling has the
advantages of washing out the plasma and the majority of
platelets and of reducing the impact of the great variability
of individual responsiveness [33]. This may be particu-
larly important for in vitro testing of agonists and drugs.
Basophil electronic capture was very efficient by using a
HLADRnon expressing/CD123bright gating strategy. Although
CD203c is a selective marker for basophilic cells, we did
not choose this molecule as phenotyping tracer since the
brighter CD123 revealed as a better marker to separate
cells and because we used the CD203c for activation stud-
ies.
Basophils appeared as highly responsive to agonist trig-
gering in a time-course and dose-response manner. We
explored several classic markers that were previously
described in the literature [9,14,34-36], with the aim to
investigate their expression in our experimental system,
their possible advantages and features.
After basophil treatment with fMLP and with anti-IgE, an
increase in MFI of CD63, CD203c, CD45 and CD13 was
observed (the latter only with fMLP), while CD69, used by
others as activation marker [1,17,37-39], did not show
appreciable changes in these conditions. This discrepancy
with our data may be due to the fact that the cited proto-
cols using CD69 introduce interleukin-3 as priming agent
[40]. Among the five activation markers tested, the most
sensitive, reproducible and evident differences with
respect to the resting state were noted using CD63 and
CD203c. However, these two markers behave in a quite
different way: cells "non responding" to fMLP or anti-IgE
(when evaluated using CD63) are fully responsive to the
same agonists when evaluated using CD203c. This obser-
vation may have clinical and laboratory importance since
in the literature the existence of "non responder" individ-
uals in basophil activation tests has been reported
[12,41]. If only CD203c is able to trigger full functional
activation of basophils, the identification and diagnosis of
the so-called "non responder" individuals in clinical lab-
Dot plots and histograms of CD63 and CD203c expression in response to anti-IgE Figure 3
Dot plots and histograms of CD63 and CD203c expression in response to anti-IgE. Basophils were incubated in the 
absence (A,B,E,G) and in the presence (C,D,F,H) of 10 μg/ml goat anti-IgE at 37°C for 30 minutes and gated basophils were 
plotted both as dot plots (A,B,C,D) and as histograms (E,F,G,H).Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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Biparametric dot plots of CD63 and CD203c expression Figure 4
Biparametric dot plots of CD63 and CD203c expression. Biparametric dot plots showing CD63 and CD203c in resting 
basophils (A) and after activation with 100 nM fMLP (B) or with 10 μg/ml goat anti-IgE (C).Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
Page 9 of 14
(page number not for citation purposes)
oratory analysis should be performed by employing at
least two markers of activation and not the single CD63.
In our experimental setting very low doses of fMLP or
anti-IgE triggered a clear-cut CD63 and CD203c expres-
sion when we started from a fully resting condition. Due
to its sensitivity, this approach may be suitable to evaluate
this pattern also in drug hypersensitivity and allergy diag-
nosis. In dose response curves of fMLP, the full expression
of CD203c precedes by one-two orders of magnitude the
full expression of CD63. This indicates that low doses of
the bacterial peptide mobilize one or more intracellular
transduction pathways that are fully competent for trig-
gering CD203c, but not CD63. This observation may have
a physiological meaning, as CD203c is an ecto-nucleoti-
dase, belonging to the nucleotide pyrophoshatase/phos-
phodiesterase family, that may be useful on the basophil
membrane for other, subtle, regulatory changes, possibly
related to purinergic signaling [42-44]. Alternatively, the
ectoenzyme may be involved in the preparation (priming)
to degranulation events. However, this hypothesis does
not fit with the time-course experiment where, at optimal
fMLP doses, the CD63 expression (degranulation) peaks
at 1 min while CD230c requires 3–5 minutes to optimal
expression.
With anti-IgE and calcium ionophore as agonists, the two
markers behaved in a similar way in the dose-response
curve, suggesting that the discrepancy between the two
markers, noted with fMLP, is receptor-specific and does
not belong to a calcium-activated pathway. It is tempting
to speculate that fMLP, being both a chemotactic factor
and a degranulating agonist, requires some specific regu-
lation, which may be more sophisticated and flexible than
those required by anti-IgE, the latter being a substance
that mimics the physiologic way of basophil activation
that induces the histamine release. Interestingly, in
Intracellular CD63 Figure 5
Intracellular CD63. Dot plots (A,C) and histograms (B,D) of CD63-associated fluorescence in normal (A,B) and saponin-
permeabilized human basophils (C,D). See text for methods.Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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fMLP and anti-IgE dose response of CD63 and CD203c expression Figure 6
fMLP and anti-IgE dose response of CD63 and CD203c expression. fMLP (a) and goat anti-human IgE dose response 
(b) of the activation markers CD63 and CD203c in a typical triplicate experiment of four performed. Basophils were incubated 
for 30 minutes at 37°C.Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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Time course of CD63 and CD203c expression Figure 7
Time course of CD63 and CD203c expression. Basophils were incubated with 10-7 M fMLP at 37°C and activation 
stopped with cold HEPES-buffered solution containing 2.8 mM Na2-EDTA.
Expression of CD203c in CD63non expressing human basophils Figure 8
Expression of CD203c in CD63non expressing human basophils. Basophils were incubated for 30 minutes at 37°C in the 
presence of different concentrations of fMLP and the MFI of CD203c was evaluated in the subset of CD63non expressing basophils.Clinical and Molecular Allergy 2008, 6:12 http://www.clinicalmolecularallergy.com/content/6/1/12
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human neutrophils intracellular calcium release and actin
polymerization require fMLP doses much lower than
those necessary for superoxide production activation and
lysozyme release [45,46], suggesting the existence of dual
pathways of regulation in both leukocyte types. This indi-
cates that all the cells have normal fMLP receptors and are
functional; moreover, all the cells are positive upon intra-
cellular staining of CD63. Therefore, our data suggest the
existence of a main subpopulation of fully viable and
responsive, but non degranulating basophils in human
blood, and this is in agreement with other, independent,
observations [47,48].
Conclusion
In summary the results from this multiparametric
approach suggest:
a) CD63 is the most sensitive and early activation marker
of human basophils, in agreement with previous evidence
from literature. However, CD63 is expressed in only a
minority of basophils even at optimal agonist doses,
while it is present in all the cells as intracellular pool.
b) CD203c is less sensitive as activation marker, because
there is a substantial expression also in the resting state.
On the other hand, this marker is upregulated in all the
cells following activation, also in those that are not iden-
tified as activated using CD63.
c) The dose-response curves show a receptor-specific
(observed with fMLP but not with anti-IgE and calcium
ionophore) dissociation between the two activation
markers. This evidence suggests that the molecule marked
by CD203c is associated with the low-dose events of
chemotaxis while the molecule CD63 is associated with
degranulation, as previously reported.
d) An overall view of several activation molecules within
the same experiment, using pooled cell preparations
could be an affordable tool to investigate the pharmacol-
ogy of basophil activation. Testing other basophil agonists
and deepening the knowledge of the transduction path-
ways and of gene expression may substantiate these views.
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